Global Liver Cancer Drug Market to Reach USD 7.83 Billion by 2030: Innovative treatments like oncolytic viruses and RNA interference (RNAi) have gained market traction
April 10, 2024 04:04 ET
|
Research and Markets
Dublin, April 10, 2024 (GLOBE NEWSWIRE) -- The "Liver Cancer Drug Market Size, Share & Trends Analysis Report By Drug Class (Targeted Therapy, Immunotherapy, Chemotherapy), By Region, And...
Immuno-Oncology Market Poised for Substantial Growth, Driven by Advanced Technologies and Biomarker Integration
January 31, 2024 08:10 ET
|
Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Immuno-Oncology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application,...
Metastatic Cancer Drugs Market Size Set to Expand Globally
January 18, 2024 21:23 ET
|
Research and Markets
Dublin, Jan. 18, 2024 (GLOBE NEWSWIRE) -- The "Metastatic Cancer Drugs Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The metastatic cancer drugs market is...
Global Cancer Therapeutics Market (2023-2028): Cancer Chemotherapy Dominates Market - A Closer Look at Therapeutic Types
September 07, 2023 05:58 ET
|
Research and Markets
Dublin, Sept. 07, 2023 (GLOBE NEWSWIRE) -- The "Global Cancer Therapeutics Market (2023-2028) by Therapeutic Type, Drug Type, Application, End-User and Geography, Competitive Analysis, Impact of...
TIGIT Inhibitors Revolutionize Immune System Control: A Comprehensive Analysis of Clinical Trials and Market Dynamics
September 06, 2023 10:34 ET
|
Research and Markets
Dublin, Sept. 06, 2023 (GLOBE NEWSWIRE) -- The "Anti TIGIT Antibody Market Opportunity and Clinical Trials Insight 2024" report has been added to ResearchAndMarkets.com's offering. The report...
Global Intratumoral Cancer Therapies Market Report 2023: Increasing Incidence of Cancer is Expected to Propel Growth
June 16, 2023 05:08 ET
|
Research and Markets
Dublin, June 16, 2023 (GLOBE NEWSWIRE) -- The "Intratumoral Cancer Therapies Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides...
Checkpoint Inhibitors Clinical Trial Pipeline Appears Robust with 180+ Key Pharma Players Actively Working in the Space, Estimates DelveInsight
May 10, 2023 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, May 10, 2023 (GLOBE NEWSWIRE) -- Checkpoint Inhibitors Clinical Trial Pipeline Appears Robust with 180+ Key Pharma Players Actively Working in the Space, Estimates DelveInsight The...
Global Checkpoint Inhibitors Competitive Landscape Report 2023: Comprehensive Insights About 180+ Companies and 250+ Drug Profiles
May 08, 2023 06:48 ET
|
Research and Markets
Dublin, May 08, 2023 (GLOBE NEWSWIRE) -- The "Checkpoint Inhibitors - Competitive landscape, 2023" report has been added to ResearchAndMarkets.com's offering.This "Checkpoint inhibitors -...
Global Checkpoint Inhibitors Market Report 2023: Rising Number of Cancer Cases Drives Growth
April 24, 2023 13:18 ET
|
Research and Markets
Dublin, April 24, 2023 (GLOBE NEWSWIRE) -- The "Checkpoint Inhibitors Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides strategists,...
Immune Checkpoint Inhibitors Clinical Trial Analysis 2022: Wide Variety of Clinical and Preclinical Research Currently Ongoing Bodes Well for Growth
December 15, 2022 05:18 ET
|
Research and Markets
Dublin, Dec. 15, 2022 (GLOBE NEWSWIRE) -- The "Immune Checkpoint Inhibitors: Analysis of Clinical Trial Results (Featuring Recently Published Trial Results, Contemporary Pipeline Review, Clinical...